Brain Metastasis from EGFR ‐Mutated Non‐Small Cell Lung Cancer: Secretion of IL11 from Astrocytes Up‐Regulates PDL1 and Promotes Immune Escape
Advanced Science · 2024-07 · 11 (26)
DOI: 10.1002/advs.202306348 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 02.05.2024. Verfasst von Mengyi Tang und 11 weiteren Autor:innen. Beteiligte Einrichtung: the Second Affiliated Hospital of Dalian Medical University, 467 Zhongshan Road, Dalian, 116027, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, B7-H1 Antigen, Lung Neoplasms, ErbB Receptors. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of China, Liaoning Revitalization Talents Program, Science and Technology Innovation Foundation of Dalian.
Abstract (Originalsprache)
Patients who have non‐small cell lung cancer (NSCLC) with epidermal growth factor receptor ( EGFR ) mutations are more prone to brain metastasis (BM) and poor prognosis. Previous studies showed that the tumor microenvironment of BM in these patients is immunosuppressed, as indicated by reduced T‐cell abundance and activity, although the mechanism of this immunosuppression requires further study. This study shows that reactive astrocytes play a critical role in promoting the immune escape of BM from EGFR ‐mutated NSCLC by increasing the apoptosis of CD8 + T lymphocytes. The increased secretion of interleukin 11(IL11) by astrocytes promotes the expression of PDL1 in BM, and this is responsible for the increased apoptosis of T lymphocytes. IL11 functions as a ligand of EGFR, and this binding activates EGFR and downstream signaling to increase the expression of PDL1, culminating in the immune escape of tumor cells. IL11 also promotes immune escape by binding to its intrinsic receptor (IL11Rα/glycoprotein 130 [gp130]). Additional in vivo studies show that the targeted inhibition of gp130 and EGFR suppresses the growth of BM and prolongs the survival time of mice. These results suggest a novel therapeutic strategy for treatment of NSCLC patients with EGFR mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- the Second Affiliated Hospital of Dalian Medical University, 467 Zhongshan Road, Dalian, 116027, China.
- Laboratory of Molecular Modeling and Design, State Key Laboratory of Molecular Reaction Dynamics, Dalian Institute of Chemical Physics, Chinese Academy of Science, 457 Zhongshan Road, Dalian, 116023, China.
- Cancer Translational Medicine Research Center, The Second Hospital, Dalian, Medical University, 467 Zhongshan Road, Dalian, 116027, China.
ORCID-Profile: Qi Wang
Förderung
- Natural Science Foundation of China
- Liaoning Revitalization Talents Program
- Science and Technology Innovation Foundation of Dalian
- Liaoning Clinical Medical Research Center Construction Program
- Dalian Science and Technology Talent Innovation Support Plan
- National Key R&D Program of China
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Tang, M., Xu, M., Wang, J., Liu, Y., Liang, K., Jin, Y., Duan, W., Xia, S., Li, G., Chu, H., Liu, W., & Wang, Q. (2024). Brain Metastasis from EGFR ‐Mutated Non‐Small Cell Lung Cancer: Secretion of IL11 from Astrocytes Up‐Regulates PDL1 and Promotes Immune Escape. Advanced Science, 11(26). https://doi.org/10.1002/advs.202306348
Vancouver
Tang M, Xu M, Wang J, Liu Y, Liang K, Jin Y, et al. Brain Metastasis from EGFR ‐Mutated Non‐Small Cell Lung Cancer: Secretion of IL11 from Astrocytes Up‐Regulates PDL1 and Promotes Immune Escape. Advanced Science. 2024;11(26). doi:10.1002/advs.202306348
BibTeX
@article{Tang2024,
author = {Tang, Mengyi and Xu, Mingxin and Wang, Jian and Liu, Ye and Liang, Kun and Jin, Yinuo and Duan, Wenzhe and Xia, Shengkai and Li, Guohui and Chu, Huiying and Liu, Wenwen and Wang, Qi},
title = {Brain Metastasis from EGFR ‐Mutated Non‐Small Cell Lung Cancer: Secretion of IL11 from Astrocytes Up‐Regulates PDL1 and Promotes Immune Escape},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {26},
doi = {10.1002/advs.202306348}
}
EUVIMED